FDA Warns that Zyprexa, Symbyax May Cause Dangerous Reaction
Earlier this month, the U.S. Food and Drug Administration made an announcement regarding the safety of using a number of mental health drugs. According to the statement, Zyprexa, Zyprexa Zydis, Zyprexa Replrevv, and Symbyax may cause patients to develop serious complications, such as facial swelling, swelling in the lymph glands, and fevers accompanied with a rash. These symptoms are referred to as Drug Reaction with Eosinophilia and Systemic Symptoms, or DRESS.
A patient experiencing DRESS may first identify a rash on his or her body that begins to spread. Swelling in the face or lymph glands occurs due to a higher-than-average reaction of infection-fighting white blood cells to the situation. This is called eosinophils.
So far, there have been 23 known reports of patients who have experienced DRESS while taking these drugs, which are olanzapine-based. The first product containing olanzapine was approved by the FDA in 1996. The drug has been prescribed to treat mental health conditions like bipolar disorder and schizophrenia. While Zyprexa, Zyprexa Zydis, Zyprexa Relprevv, and Symbyax are the common names under which olanzapine is sold, there are also generic brands for the drug.
Illinois Injury and Mass Tort Lawyer Blog




